Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$2.05B |
| 2 |
Texas Instruments
TXN
|
+$1.69B |
| 3 |
NVIDIA
NVDA
|
+$1.36B |
| 4 |
Starbucks
SBUX
|
+$1.2B |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$949M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.77B |
| 2 |
Microsoft
MSFT
|
+$1.3B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$1.22B |
| 4 |
iShares US Real Estate ETF
IYR
|
+$1.11B |
| 5 |
Procter & Gamble
PG
|
+$915M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.33% |
| 2 | Consumer Discretionary | 7.25% |
| 3 | Financials | 7.18% |
| 4 | Communication Services | 6.16% |
| 5 | Healthcare | 5.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2426
Sixth Street Specialty
TSLX
$1.78B
| $1.17M | ﹤0.01% |
54,830
-25,583
| -32% | -$545K |
|
2427
Orthofix Medical
OFIX
$422M
| $1.17M | ﹤0.01% |
88,262
-69,515
| -44% | -$953K |
|
2428
Federal Agricultural Mortgage
AGM
$2.56B
| $1.17M | ﹤0.01% |
6,451
-5,223
| -45% | -$943K |
|
2429
Urban Outfitters
URBN
$6.64B
| $1.16M | ﹤0.01% |
28,338
-28,461
| -50% | -$1.17M |
|
2430
Pricesmart
PSMT
$5.7B
| $1.16M | ﹤0.01% |
14,272
-12,792
| -47% | -$1.05M |
|
2431
BGC Group
BGC
$4.92B
| $1.16M | ﹤0.01% |
139,545
-185,805
| -57% | -$1.53M |
|
2432
Walker & Dunlop
WD
$1.46B
| $1.16M | ﹤0.01% |
11,772
-17,258
| -59% | -$1.64M |
|
2433
Montauk Renewables
MNTK
$236M
| $1.15M | ﹤0.01% |
202,004
-22,337
| -10% | -$103K |
|
2434
Cheesecake Factory
CAKE
$5.35B
| $1.15M | ﹤0.01% |
29,295
-13,882
| -32% | -$514K |
|
2435
Genworth Financial
GNW
$3.72B
| $1.15M | ﹤0.01% |
190,391
-301,522
| -61% | -$1.88M |
|
2436
BioLife Solutions
BLFS
$1.65B
| $1.15M | ﹤0.01% |
53,620
+5,566
| +12% | +$108K |
|
|
SOHU
2437
Sohu.com
SOHU
$368M
| $1.15M | ﹤0.01% |
82,543
| – | – |
|
2438
Camden National
CAC
$988M
| $1.15M | ﹤0.01% |
34,797
-7,269
| -17% | -$229K |
|
|
TEM
2439
CALL
Tempus AI
TEM
$8.34B
| $1.15M | ﹤0.01% |
+32,800
| New | +$1.01M |
|
2440
National Health Investors
NHI
$3.63B
| $1.15M | ﹤0.01% |
16,921
-22,503
| -57% | -$1.44M |
|
2441
Privia Health
PRVA
$2.67B
| $1.14M | ﹤0.01% |
65,830
-52,988
| -45% | -$939K |
|
|
OKYO
2442
OKYO Pharma
OKYO
$80.3M
| $1.14M | ﹤0.01% |
961,000
+105,113
| +12% | +$147K |
|
2443
Keros Therapeutics
KROS
$204M
| $1.14M | ﹤0.01% |
24,992
-44,664
| -64% | -$2.4M |
|
2444
Asana
ASAN
$1.96B
| $1.14M | ﹤0.01% |
81,639
-42,214
| -34% | -$602K |
|
2445
Birkenstock
BIRK
$6.82B
| $1.14M | ﹤0.01% |
20,913
+20,150
| +2,641% | +$999K |
|
2446
Allegro MicroSystems
ALGM
$7.98B
| $1.14M | ﹤0.01% |
40,203
-38,195
| -49% | -$1.09M |
|
|
ALLK
2447
DELISTED
Allakos
ALLK
| $1.13M | ﹤0.01% |
1,134,018
-25,336
| -2% | -$30.1K |
|
2448
State Street SPDR Dow Jones Global Real Estate ETF
RWO
$1.3B
| $1.13M | ﹤0.01% |
27,271
+1,020
| +4% | +$42K |
|
|
FOLD
2449
CALL
DELISTED
Amicus Therapeutics
FOLD
| $1.13M | ﹤0.01% |
+114,000
| New | +$1.17M |
|
2450
ProShares UltraPro QQQ
TQQQ
$36.9B
| $1.13M | ﹤0.01% |
30,506
+3,506
| +13% | +$110K |
|
Similar funds
Barclays's Q2 2024 Portfolio in Review
As of Q2 2024, Barclays held 5,455 positions worth $327B, up 14% from $288B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Barclays deployed $29.4B of net new capital in Q2 2024, opening 406 new positions and adding to 1,053 existing holdings. Its largest new stake was Ferrovial N.V. Ordinary Shares: 4,837,593 shares worth $186M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 24% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Apple, an estimated $2.77B trimmed.
- Barclays's largest Q2 2024 buy was Ferrovial N.V. Ordinary Shares: 4,837,593 shares worth $186M.
- Barclays added most to CRH in Q2 2024, an estimated $2.05B increase.
- Barclays's biggest Q2 2024 reduction was Apple, cutting an estimated $2.77B.
- Barclays fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $212M.
- Barclays's ten largest holdings make up 42% of its $327B portfolio in Q2 2024.
- Barclays opened 406 new positions and closed 646 in Q2 2024.
- Barclays's portfolio value rose 14% quarter-over-quarter to $327B.
Based on Barclays's 13F filing for Q2 2024, filed 14 Aug 2024.